REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/13/2025
Back to search
Official data from USPTO
RIBOTECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RIBOTECT
ST13
US500000079268012Class
5, 42, 44
Filing
79268012
Registration
6171861
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
10/14/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
08/06/2019
Registration date
10/13/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/13/2020
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
RUTLAND,BARBARA A
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
B. S. (pessoa física)
BioNTech RNA Pharmaceuticals GmbH
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomeslipoplexespolyplexesmicroparticlesnanoparticleslipid-based emulsions for the treatment and prevention of cancerous diseasesinfectious diseasesautoimmune disordersgenetic defects or metabolic disorders; Medical and pharmaceutical preparations comprisingin particularliposomeslipoplexespolyplexesmicroparticlesnanoparticleslipid-based emulsions and comprising additional active ingredientsin particular proteins or nucleid acids for the treatment and prevention of cancerous diseasesinfectious diseasesautoimmune disordersgenetic defects or metabolic disorders; Carriers and carrier systemsdrug delivery agents in the form of powderstabletsliposomeslipoplexespolyplexesmicroparticlesnanoparticleslipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancerinfectious diseasesautoimmune disordersgenetic defectsmetabolic disorders
Class 42
Scientific research for medical and veterinary purposesin particular for treatment of cancerinfectious diseasesautoimmune disordersgenetic defectsmetabolic disordersusing liposomeslipoplexespolyplexesmicroparticlesnanoparticlesemulsions
Class 44
Medical and veterinary services in connection with cancer diseasesinfectious diseasesautoimmune disordersgenetic defectsmetabolic disorders
Publications
History of USPTO decisions and trademark events.
33 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/31/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/30/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/30/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/30/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/30/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/30/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/30/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/19/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/29/2021
FIMP
FINAL DISPOSITION PROCESSED
01/29/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/13/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/13/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/31/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/28/2020
PUBO
PUBLISHED FOR OPPOSITION
07/28/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/15/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/28/2020
RFNT
REFUSAL PROCESSED BY IB
12/20/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/30/2019
RFRR
REFUSAL PROCESSED BY MPU
11/30/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/10/2019
CNRT
NON-FINAL ACTION WRITTEN
11/09/2019
DOCK
ASSIGNED TO EXAMINER
11/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/26/2019
Continuous trademark protection
Get notified about every new filing that threatens RIBOTECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.